Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 27, 2004Journal of Clinical Oncology

High-Dose Chemotherapy With Autologous Hematopoietic Stem-Cell Support Compared With Standard-Dose Chemotherapy in Breast Cancer Patients With 10 or More Positive Lymph Nodes: First Results of a Randomized Trial

View Full Paper
Ask AI
Bookmark
Share

Authors

AZA R ZanderNKNicolaus KrögerCSClaudia Schmoor

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zander et al. (2004) studied this question.

synapsesocial.com/papers/6a82b186d7a462ab0d8ade48https://doi.org/10.1200/jco.2004.07.026
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Regimen-related toxicity in patients undergoing bone marrow transplantation.1988 · 891 citations
  2. 2The importance of dose intensity in chemotherapy of metastatic breast cancer.1984 · 896 citations
  3. 3Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer.1986 · 460 citations
  4. 4Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes.1991 · 163 citations
  5. 5Randomized Trial of High-Dose Chemotherapy and Blood Cell Autografts for High-Risk Primary Breast Carcinoma2000 · 169 citations